Sales & Marketing News | pharmaphorum

News

FDA clears first gene therapy for rare genetic disease WAS

Fondazione Telethon's Waskyra has become the first gene therapy in the US for Wiskott-Aldrich syndrome, and the first taken to market by a non-profit.

News

UK confirms lower clawback rate for NHS medicines

The UK has cut its voluntary rebate rate for new medicines supplied to the NHS to 14.5% next year, but industry says this is "only the first step."

News

Antibiotic is first approval in FDA national priority scheme

FDA approves its first 'national priority' drug – a version of the widely used antibiotic Augmentin XR – in double-quick time.

News

ASH: FDA okays Gamida aplastic anaemia therapy as data drops

The first cell therapy for severe aplastic anaemia – Gamida Cell's Omisirge – has been approved by the FDA.

News

CDC panel votes to scrap hepatitis B birth dose advice

CDC advisers vote to overturn decades of US policy and abandon endorsement of universal hepatitis B vaccination for newborns in the US.

News

BMS's Breyanzi is first CAR-T for marginal zone lymphoma

Bristol Myers Squibb has taken CAR-T therapy into new territory, after getting FDA approval for Breyanzi in marginal zone lymphoma.

FDA clears first gene therapy for rare genetic disease WAS

UK confirms lower clawback rate for NHS medicines

Antibiotic is first approval in FDA national priority scheme

ASH: FDA okays Gamida aplastic anaemia therapy as data drops

CDC panel votes to scrap hepatitis B birth dose advice

BMS's Breyanzi is first CAR-T for marginal zone lymphoma

Ultragenyx to slash costs after Angelman trial failure

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks